Standard BioTools Inc.LABNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P0
Near historical low
vs 5Y Ago
-20.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -71.64% |
| Q3 2025 | -10.76% |
| Q2 2025 | -46.16% |
| Q1 2025 | -9.88% |
| Q4 2024 | -5.83% |
| Q3 2024 | 124.22% |
| Q2 2024 | -57.11% |
| Q1 2024 | 81.09% |
| Q4 2023 | 19.75% |
| Q3 2023 | -18.00% |
| Q2 2023 | 10.76% |
| Q1 2023 | 9.98% |
| Q4 2022 | 21.12% |
| Q3 2022 | 108.27% |
| Q2 2022 | -63.82% |
| Q1 2022 | -39.55% |
| Q4 2021 | 48.09% |
| Q3 2021 | -16.76% |
| Q2 2021 | -13.76% |
| Q1 2021 | -27.37% |
| Q4 2020 | 3.55% |
| Q3 2020 | 65.07% |
| Q2 2020 | -6.77% |
| Q1 2020 | -8.03% |
| Q4 2019 | 27.43% |
| Q3 2019 | -8.62% |
| Q2 2019 | -9.58% |
| Q1 2019 | -9.68% |
| Q4 2018 | 18.89% |
| Q3 2018 | 16.44% |
| Q2 2018 | 1.19% |
| Q1 2018 | -6.01% |
| Q4 2017 | 17.27% |
| Q3 2017 | 1.96% |
| Q2 2017 | -11.91% |
| Q1 2017 | -2.03% |
| Q4 2016 | 16.42% |
| Q3 2016 | -24.16% |
| Q2 2016 | -7.86% |
| Q1 2016 | -6.15% |